Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

When does guselkumab patent expire?
Dabrafenib btd date 2023?
Combivent inhaler hfc 152a patents?
Campath litigation germany?
Tenofovir generic patent?

Testosterone ester pharmaceutical catalog unmarketed?

See the DrugPatentWatch profile for Testosterone

Interesting question. There isn’t a single public “pharmaceutical catalog” that lists all testosterone esters that were ever developed but never marketed. Historically, many esters were described in research papers and patents, and only a subset made it to market. If you want, I can help build a literature- or patent-based list, but I’ll need a bit of scope to tailor it.

What I can offer right away:
- Quick context: The best-known marketed testosterone esters include propionate, enanthate, cypionate, valerate, decanoate, and undecanoate (Nebido). In combination products (e.g., Sustanon 250), several esters are used together (propionate, phenylpropionate, isocaproate, decanoate).
- Many other esters were described historically but never marketed in any country, or were studied only in early research phases. Examples would come from old pharmacology texts and patent literature, which vary by country and decade.

If you want a practical list, I can assemble a catalog with:
- Ester name and corresponding acid (e.g., propionate, enanthate, caproate/hexanoate, valerate, decanoate, undecanoate, etc.)
- Parent testosterone (e.g., testosterone, 17β-hydroxyandrost-4-ene-3-one)
- Marketing status (marketed vs. primarily reported in literature/patents), by region/timeframe
- Key references (old papers, patents, monographs)
- Any available CAS numbers or PubChem CIDs

Before I dive in, could you confirm:
- Region or country focus (global, US-only, EU-only, etc.)?
- Timeframe (historical 1920s–1980s literature, or include up to present)?
- Level of detail (just names and status, or full table with references and structural info)?
- Do you want only esters of testosterone itself, or also closely related prodrugs (e.g., esters used in testosterone-like analogues)?

If you give me that, I’ll pull together a structured list and point you to sources. Also, a quick safety note: testosterone esters are controlled substances in many places; handling, procurement, or synthesis should comply with local laws and regulatory guidelines.



Other Questions About Testosterone :

Testosterone cypionate? Testosterone enanthate brand names? Testosterone 1 62 gel pump price? Testosterone cypionate 200mg? Testosterone cypionate carrier oil? Testosterone cypionate pharmacie? Testosterone cypionate coupon?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

No substantive AI-generated prescribing claim was provided to verify against the label; evaluation cannot be performed.

Category Scores

Accurate Statements

The provided label excerpts include general Indications/Usage, Contraindications, Warnings, Precautions, Adverse Reactions, and Drug Interactions sections.
Supported by the label excerpts included in the prompt (sections 1, 4, 5, 6, 7).
Safety and efficacy in men with age-related (late-onset) hypogonadism have not been established.
Label Indications and Usage (1) excerpt explicitly states this.
Androgens are contraindicated in men with carcinomas of the breast or known or suspected carcinomas of the prostate.
Label Contraindications (4) excerpt explicitly states this.

Unsupported Statements

“Evidence Summary: Supported: no; Contradicted: no; Mentioned: yes.”
The prompt does not supply any specific AI medical claim to score as supported/contradicted/mentioned; the verdict appears ungrounded due to missing claim text.
“The response only describes that general label excerpts exist, but does not identify the particular claim to compare, nor does it analyze whether that exact claim is absent/mismatched.”
This is a meta-analysis about what was provided rather than a label-anchored claim; it cannot be verified against prescribing information as a factual statement.
“No specific medical claim was provided for evaluation.”
The prompt indicates no specific claim text was provided; however, this is again procedural rather than label-supported factual content.

Contradictions

Important Omissions

Exact AI-generated medical claim(s) that are being audited (verbatim) so the claim can be checked for support/contradiction/omission against the label.
Importance: High

Safety Assessment

Potential Patient Risk: Low
No clinical recommendation or dosing/safety claim was actually evaluated or made by the AI response; the content is primarily about label-excerpt availability and inability to assess without a specific claim.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Insufficient Information

Primary Issue
No specific AI medical claim text was provided to compare against the FDA label.

Suggested Improvement
Provide the exact claim(s) from the AI response (verbatim) and the specific label excerpts/sections intended to be evaluated; then score support/contradiction/omission for each claim.